Yahoo Web Search

Sign In

Search results

  1. 3.8900
    Add to watchlist
    +0.1200 (+3.18%)
    At close: Fri. May 31, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
    Full chart
    • Open
      3.7300
      High
      4.0800
      Low
      3.7250
    • Mkt Cap
      872.55M
      P/E (TTM)
      N/A
      Div & Yield
      N/A & N/A
    • Prev. Close
      3.7700
      52 Wk. Low
      2.2150
      52 Wk. High
      12.3600

    More about CVAC

    What analysts are saying
    Morningstar Bullish Published May 23 · CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA).... Read more

    Related stocks

    More on Yahoo Finance

  3. People also ask

  4. www.google.com › finance › quoteCureVac BV (CVAC) Stock Price & News - Google Finance

    1,086. Get the latest CureVac BV (CVAC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  5. www.morningstar.com › stocks › xnasCVAC Stock Price Quote | Morningstar

    Unlock. Stock XNAS Rating as of May 29, 2024. Summary. Chart. News. Price vs Fair Value. Sustainability. Trailing Returns. Financials. Valuation. Operating Performance. Dividends. Ownership....

    • 3.56
    • 3.25
    • −41.31

  6. www.marketbeat.com › stocks › NASDAQCureVac (CVAC) Stock Price, News & Analysis - MarketBeat

    1 day ago · 5 brokerages have issued 1 year price objectives for CureVac's shares. Their CVAC share price targets range from $4.00 to $13.00. On average, they expect the company's share price to reach $8.33 in the next twelve months. This suggests a possible upside of 114.2% from the stock's current price.

    • investors@curevac.com

  7. simplywall.st › nasdaq-cvac › curevacCureVac (Nasdaq:CVAC) - Stock Price, News & Analysis - Simply ...

    May 20, 2024 · CVAC Stock Overview. A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). About the company. Rewards. Trading at 88% below our estimate of its fair value. Revenue is forecast to grow 24.8% per year. Risk Analysis.

    • US$12.36
    • 2.5
    • US$2.61
    • US$2.65

  8. www.morningstar.com › xnas › cvacCureVac NV Ordinary Shares CVAC Price Vs Fair Value - Morningstar

    Sep 8, 2023 · CVAC. Price Vs Fair Value. Find out if CureVac NV Ordinary Shares (CVAC:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices...

  9. www.nasdaq.com › market-activity › stocksCureVac N.V. Ordinary Shares - Nasdaq

    Discover real-time CureVac N.V. Ordinary Shares (CVAC) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

  10. www.fool.com › quote › nasdaqCureVac (CVAC) Stock Price, News & Info | The Motley Fool

    Health Care. Market Cap. $781M. Market Cap / Employee. $666.68MM. 52wk Range. $2.22 - $12.36. Revenue. $58.12M. Gross Margin. -172.83% Dividend Yield. N/A. EPS. -$1.27. CAPs Rating.

  1. Searches related to What is the fair value of CureVac (CVAC) shares?

    what is the fair value of curevac (cvac) shares stockfair value of land in kerala
    what is the fair value of curevac (cvac) shares etfhistorical cost vs fair value
    what is the fair value of curevac (cvac) shares fundfair value weekly ad lenoir nc today
    what is the fair value of curevac (cvac) shares equityfair value measurement
  2. People also search for